Recent Articles from MarketBeat
MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Website: https://www.marketbeat.com
CytomX Therapeutics Q3 Earnings Call Highlightsmarketbeat.com
CytomX Therapeutics (NASDAQ:CTMX) plans to provide a January update on its lead cancer drug candidate, Varseta-M, as it prepares for a potential registrational study in metastatic colorectal cancer in the first half of 2027.
The update is expected to include the first look at overall survival data
Via MarketBeat · November 5, 2026
Clarus Q3 Earnings Call Highlightsmarketbeat.com
Clarus (NASDAQ:CLAR) raised its 2026 adjusted earnings outlook after third-quarter revenue growth and margin gains at its Black Diamond outdoor business offset a sales decline in its Adventure segment.
The company reported third-quarter sales of $71.2 million, up from $69.3 million a year earlier.
Via MarketBeat · November 5, 2026
First Horizon Sees 4% Earnings Boost From $4.5 Billion Mortgage Salemarketbeat.com
First Horizon (NYSE:FHN) expects its $4.5 billion mortgage portfolio sale to boost earnings and profitability in 2027, while giving the regional bank more flexibility to fund commercial and specialty lending, Chief Financial Officer Hope Dmuchowski said at an investor event.
The transaction, which
Via MarketBeat · November 5, 2026
Astrana Health Q3 Earnings Call Highlightsmarketbeat.com
Astrana Health (NASDAQ:ASTH) reported record third-quarter revenue and adjusted EBITDA as growth in Medicare Advantage membership and full-risk contracts helped offset declines in Medicaid and exchange enrollment.
Revenue rose 7% year over year to $1.02 billion for the quarter ended Sept. 30, 2026,
Via MarketBeat · November 5, 2026
What Celcuity (CELC) Said on Its Q3 Earnings Callmarketbeat.com
Celcuity (NASDAQ:CELC) reported a wider third-quarter loss as it prepared to commercialize its breast cancer treatment REVTORPYK, while executives said early orders and insurance coverage pointed to an encouraging launch.
The company recorded no product revenue in the quarter ended Sept. 30, 2026.
Via MarketBeat · November 5, 2026
What Castle Biosciences (CSTL) Said on Its Q3 Earnings Callmarketbeat.com
Castle Biosciences (NASDAQ:CSTL) raised its full-year revenue outlook after reporting 24% third-quarter revenue growth, driven primarily by demand for its TissueCypher test.
The company reported revenue of $102.9 million for the quarter and now expects 2026 revenue of $385 million to $395 million,
Via MarketBeat · November 5, 2026
Century Aluminum Q3 Earnings Call Highlightsmarketbeat.com
Century Aluminum (NASDAQ:CENX) reported third-quarter net sales of nearly $1 billion and adjusted EBITDA of $332 million as higher aluminum prices and increased shipments followed production restarts at its Mt. Holly and Grundartangi facilities.
The company expects fourth-quarter adjusted EBITDA of
Via MarketBeat · November 5, 2026
What Affirm (AFRM) Said on Its Q1 Earnings Callmarketbeat.com
Affirm (NASDAQ:AFRM) expects gross merchandise volume to grow at least 30% in fiscal 2027, after reporting 34% growth in the first quarter, executives said on the company’s earnings call. Management also addressed higher provision expenses, funding costs and plans to expand its card and merchant off
Via MarketBeat · November 5, 2026
BlackLine Q3 Earnings Call Highlightsmarketbeat.com
BlackLine (NASDAQ:BL) lowered its full-year revenue outlook after longer customer decision cycles and slower professional services growth weighed on its third-quarter results, even as the accounting software company reported higher profitability and cash flow.
Third-quarter revenue rose 8.5% to $19
Via MarketBeat · November 5, 2026
What Arcturus Therapeutics (ARCT) Said on Its Q3 Earnings Callmarketbeat.com
Arcturus Therapeutics (NASDAQ:ARCT) expects to complete enrollment in a mid-stage cystic fibrosis study by the end of 2026 and begin dosing a next-generation treatment for a rare liver disorder in the first quarter of 2027, executives said on the company’s third-quarter earnings call.
The company r
Via MarketBeat · November 5, 2026
indie Semiconductor Q3 Earnings Call Highlightsmarketbeat.com
indie Semiconductor (NASDAQ:INDI) reported third-quarter revenue of $70.2 million, up 31% from a year earlier, and forecast further growth as its automotive radar chipset enters high-volume production.
The chipmaker’s revenue rose 10% sequentially and came in $0.2 million above the midpoint of its
Via MarketBeat · November 5, 2026
What Inogen (INGN) Said on Its Q3 Earnings Callmarketbeat.com
Inogen (NASDAQ:INGN) reported lower third-quarter revenue as weaker spending by large European customers offset a return to growth in U.S. sales. The respiratory care company also outlined a $20 million annualized cost-reduction program following the sale of its U.S. oxygen rental business.
Revenue
Via MarketBeat · November 5, 2026
Veeva Systems Sticks to $6 Billion Revenue Goal as AI Expands Its Market Opportunitymarketbeat.com
Veeva Systems (NYSE:VEEV) said it remains on track to reach a $6 billion revenue run rate by calendar 2030, as the life sciences software provider expands its artificial intelligence offerings and pursues more business from clinical research organizations.
At its Nov. 5 investor day, CEO Peter Gass
Via MarketBeat · November 5, 2026
ICU Medical Q3 Earnings Call Highlightsmarketbeat.com
ICU Medical (NASDAQ:ICUI) reported third-quarter revenue of $556 million and said it expects full-year adjusted earnings to finish toward the high end of its existing guidance, as growth in infusion products and improved margins offset a decline in Vital Care.
Revenue rose 4% on a reported basis an
Via MarketBeat · November 5, 2026
Green Plains Q3 Earnings Call Highlightsmarketbeat.com
Green Plains (NASDAQ:GPRE) reported record adjusted EBITDA of $118 million for the third quarter of 2026, as improved ethanol plant performance and clean fuel production tax credits helped lift earnings despite a decline in revenue.
The result more than doubled adjusted EBITDA of $53 million a year
Via MarketBeat · November 5, 2026
Five9 Q3 Earnings Call Highlightsmarketbeat.com
Five9 (NASDAQ:FIVN) reported third-quarter revenue above its guidance range as artificial intelligence deployments accelerated, and said it had agreed to acquire Level AI for $325 million in cash to expand its standalone AI offerings.
The contact center software company raised its full-year revenue
Via MarketBeat · November 5, 2026
What Fulgent Genetics (FLGT) Said on Its Q3 Earnings Callmarketbeat.com
Fulgent Genetics (NASDAQ:FLGT) reported third-quarter revenue of $90.4 million, up 8% from a year earlier, as contributions from Bako Diagnostics and StrataDx and improving collections helped lift results. The company reaffirmed its full-year revenue forecast and narrowed its projected loss.
The la
Via MarketBeat · November 5, 2026
What Guardant Health (GH) Said on Its Q3 Earnings Callmarketbeat.com
Guardant Health (NASDAQ:GH) raised its full-year 2026 revenue forecast after third-quarter sales increased 36%, driven by growth in its oncology testing business and demand for its Shield blood-based cancer screening test.
The company reported revenue of $361 million for the quarter ended Sept. 30,
Via MarketBeat · November 5, 2026
ICF International Q3 Earnings Call Highlightsmarketbeat.com
ICF International (NASDAQ:ICFI) returned to year-over-year revenue growth in the third quarter of 2026 but lowered its full-year revenue outlook after utility clients paused spending on some incremental energy-efficiency work.
The consulting and technology services company reported revenue of $470.
Via MarketBeat · November 5, 2026
What Consensus Cloud Solutions (CCSI) Said on Its Q3 Earnings Callmarketbeat.com
Consensus Cloud Solutions (NASDAQ:CCSI) reported third-quarter 2026 revenue growth of 3.7% as corporate fax demand and usage at the Department of Veterans Affairs helped offset a decline in its small office and home office business.
Revenue rose to $91 million from $87.8 million a year earlier, mar
Via MarketBeat · November 5, 2026
Corsair Gaming Q3 Earnings Call Highlightsmarketbeat.com
Corsair Gaming (NASDAQ:CRSR) raised its full-year 2026 revenue and adjusted EBITDA outlook after third-quarter sales exceeded its guidance, as strong memory demand and growth in pre-built systems offset weakness in do-it-yourself PC components.
Revenue rose 6% year over year to $367 million, exceed
Via MarketBeat · November 5, 2026
Bank of America Sees 8% Net Interest Income Growth Through 2027, Ahead of Targetmarketbeat.com
Bank of America (NYSE:BAC) said it is on track to meet the medium-term financial targets it set at its 2025 investor day, with executives pointing to loan growth, rising net interest income and technology investments as drivers of earnings and returns.
Chief Financial Officer Alastair Borthwick sai
Via MarketBeat · November 5, 2026
What AvePoint (AVPT) Said on Its Q3 Earnings Callmarketbeat.com
AvePoint (NASDAQ:AVPT) reported record net new annual recurring revenue in the third quarter of 2026 and raised its full-year ARR outlook, as demand grew for its data governance and artificial intelligence management products.
The company added $30 million in net new ARR, up 34% from a year earlier
Via MarketBeat · November 5, 2026
Diodes Q3 Earnings Call Highlightsmarketbeat.com
Diodes (NASDAQ:DIOD) reported record third-quarter revenue of $532.6 million, up 35.8% from a year earlier, as automotive demand, industrial applications and AI infrastructure helped drive growth across its end markets.
The semiconductor company also forecast fourth-quarter revenue of approximately
Via MarketBeat · November 5, 2026
Axon Enterprise Q3 Earnings Call Highlightsmarketbeat.com
Axon Enterprise (NASDAQ:AXON) reported 28% revenue growth in the third quarter, but removed three large federal counter-drone deployments from its near-term expectations as procurement and installation timelines became less certain.
The public safety technology company also announced a $1.2 billion
Via MarketBeat · November 5, 2026
What CarGurus (CARG) Said on Its Q3 Earnings Callmarketbeat.com
CarGurus (NASDAQ:CARG) reported 12% year-over-year revenue growth in the third quarter of 2026 as more dealers subscribed to its products, even as pressure on vehicle affordability and dealer margins continued to weigh on spending.
Revenue reached $258 million, at the high end of the company’s guid
Via MarketBeat · November 5, 2026
Dropbox Q3 Earnings Call Highlightsmarketbeat.com
Dropbox (NASDAQ:DBX) raised its full-year revenue and profit outlook after third-quarter sales and operating margin exceeded its guidance, while outlining plans to expand into AI infrastructure through its proposed acquisition of object-storage provider Tigris Data.
The company reported revenue of
Via MarketBeat · November 5, 2026
What Conduent (CNDT) Said on Its Q3 Earnings Callmarketbeat.com
Conduent (NASDAQ:CNDT) reported lower third-quarter revenue but improved profitability as cost reductions helped offset contract losses, and executives said converting a growing sales pipeline into revenue remains the company’s primary challenge.
Revenue from continuing operations fell to $534 mill
Via MarketBeat · November 5, 2026
What Alpha and Omega Semiconductor (AOSL) Said on Its Q1 Earnings Callmarketbeat.com
Alpha and Omega Semiconductor (NASDAQ:AOSL) reported fiscal first-quarter revenue of $177.8 million as rapid growth in AI and server applications helped offset weaker demand for traditional PCs and consumer electronics.
Revenue for the September quarter rose 4.3% from the preceding quarter but fell
Via MarketBeat · November 5, 2026
What Atlanticus (ATLC) Said on Its Q3 Earnings Callmarketbeat.com
Atlanticus (NASDAQ:ATLC) reported record third-quarter operating performance, with earnings boosted by gains from the sale of its auto finance operations and Mercury intellectual property. Management said it plans to direct the proceeds toward higher-return consumer credit businesses.
Net income at
Via MarketBeat · November 5, 2026
Box Unveils AI Agent Tools and NVIDIA Partnership at BoxWorks 2026marketbeat.com
BOX (NYSE:BOX) unveiled new artificial intelligence and security tools at its BoxWorks 2026 investor product briefing, outlining a strategy to help companies connect AI agents with their documents and automate content-heavy workflows.
The announcements included Box Context Retrieval, designed to he
Via MarketBeat · November 5, 2026
What Exp World (AGNT) Said on Its Q3 Earnings Callmarketbeat.com
Exp World (NASDAQ:AGNT) reported third-quarter revenue growth of 6% as a rise in agent transactions and its acquisition of NextHome helped offset a challenging housing market. Operating income fell 23%, however, as legal expenses weighed on results.
The company, which operates as AGNT, reported rev
Via MarketBeat · November 5, 2026
What Arteris (AIP) Said on Its Q3 Earnings Callmarketbeat.com
Arteris (NASDAQ:AIP) reported record third-quarter revenue and raised its full-year outlook, citing strong semiconductor licensing activity across artificial intelligence infrastructure and other applications.
Revenue for the quarter ended Sept. 30 rose 48% from a year earlier to $25.8 million, exc
Via MarketBeat · November 5, 2026
Amphastar Pharmaceuticals Q3 Earnings Call Highlightsmarketbeat.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported record third-quarter revenue of $207.6 million, up 8% from a year earlier, as sales of BAQSIMI and Primatene MIST and contributions from newer products offset manufacturing disruptions and lower pricing on some established medicines.
The company expe
Via MarketBeat · November 5, 2026
Allogene Therapeutics Q3 Earnings Call Highlightsmarketbeat.com
Allogene Therapeutics (NASDAQ:ALLO) expects to complete enrollment in its ALPHA3 lymphoma trial by the end of 2027, as increased screening and activity in Asia-Pacific help support recruitment, executives said on the company’s third-quarter earnings call.
The company also plans to present expanded
Via MarketBeat · November 5, 2026
What Akamai Technologies (AKAM) Said on Its Q3 Earnings Callmarketbeat.com
Akamai Technologies (NASDAQ:AKAM) expects its cloud infrastructure revenue to more than double in 2027, as it begins delivering on more than $14 billion in multiyear customer commitments signed this year. The forecast comes even as supply chain and data center delays shift some revenue out of the fo
Via MarketBeat · November 5, 2026
What Applied Optoelectronics (AAOI) Said on Its Q3 Earnings Callmarketbeat.com
Applied Optoelectronics (NASDAQ:AAOI) reported its sixth consecutive quarter of record revenue as demand for data center and cable television products more than doubled sales from a year earlier. The company also said a new hyperscale customer agreement could generate $1 billion to $1.5 billion in r
Via MarketBeat · November 5, 2026
Airbnb Q3 Earnings Call Highlightsmarketbeat.com
Airbnb (NASDAQ:ABNB) reported its fastest revenue growth in more than three years in the third quarter of 2026, as bookings accelerated across its major regions and the company raised its full-year outlook.
Revenue rose 19% year over year to $4.9 billion, while gross booking value increased 21% to
Via MarketBeat · November 5, 2026
What GSI Technology (GSIT) Said on Its Q2 Earnings Callmarketbeat.com
GSI Technology (NASDAQ:GSIT) reported fiscal second-quarter revenue of $6 million and a net loss of $7 million, as inventory shortages delayed some customer shipments and higher manufacturing costs pressured gross margin.
On its Nov. 5 earnings call, management forecast revenue of $5 million to $6
Via MarketBeat · November 5, 2026
KeyCorp Confident in $1 Billion Fee Target Despite M&A Slowdownmarketbeat.com
KeyCorp (NYSE:KEY) executives said the bank remains confident it can reach its target of $1 billion in investment banking and direct placement fees, even as middle-market merger activity remains subdued.
Randy Paine, president of Key Institutional Bank, said announced middle-market mergers and acqu
Via MarketBeat · November 5, 2026
What BJ's Restaurants (BJRI) Said on Its Q3 Earnings Callmarketbeat.com
BJ's Restaurants (NASDAQ:BJRI) raised its full-year sales and profit outlook after fiscal 2026 third-quarter traffic growth helped drive higher revenue and restaurant-level margins.
Revenue rose 8.6% to $358.6 million, while comparable restaurant sales increased 8.1%. Traffic grew 8.3%, partially o
Via MarketBeat · November 5, 2026
What Blink Charging (BLNK) Said on Its Q3 Earnings Callmarketbeat.com
Blink Charging (NASDAQ:BLNK) reported its first quarter of positive adjusted earnings before interest, taxes, depreciation and amortization, reaching the milestone ahead of its target even as revenue fell and the company lowered its full-year sales forecast.
The electric vehicle charging company po
Via MarketBeat · November 5, 2026
What Corvus Pharmaceuticals (CRVS) Said on Its Q3 Earnings Callmarketbeat.com
Corvus Pharmaceuticals (NASDAQ:CRVS) reported a wider third-quarter loss as spending on clinical trials increased, while executives outlined a series of 2027 milestones for its lead experimental drug, soquelitinib.
The company reported a net loss of $20.3 million for the third quarter of 2026, comp
Via MarketBeat · November 5, 2026
AerSale Q3 Earnings Call Highlightsmarketbeat.com
AerSale (NASDAQ:ASLE) reported a 29% increase in third-quarter revenue, but higher costs associated with expanding its maintenance operations and a goodwill impairment pushed the company to a wider net loss.
Revenue rose to $91.6 million from $71.2 million a year earlier, including a $9.3 million e
Via MarketBeat · November 5, 2026
What Biodesix (BDSX) Said on Its Q3 Earnings Callmarketbeat.com
Biodesix (NASDAQ:BDSX) reported 10% revenue growth for the third quarter of 2026 but said results fell short of its expectations as a smaller-than-planned sales force, seasonal patterns in primary care and delayed customer projects weighed on performance.
The lung diagnostics company revised its fu
Via MarketBeat · November 5, 2026
Expensify Q3 Earnings Call Highlightsmarketbeat.com
Expensify (NASDAQ:EXFY) reported third-quarter 2026 revenue of $33 million and raised its full-year free cash flow forecast, even as executives said growth in its newer platform has yet to offset declines in its legacy business.
The expense-management company generated $3.3 million in free cash flo
Via MarketBeat · November 5, 2026
Clean Energy Fuels Q3 Earnings Call Highlightsmarketbeat.com
Clean Energy Fuels (NASDAQ:CLNE) raised its 2026 adjusted EBITDA outlook after a stronger-than-expected clean fuel tax credit value helped lift third-quarter results.
The renewable natural gas supplier reported revenue of $112 million and adjusted EBITDA of $27.2 million for the quarter ended Septe
Via MarketBeat · November 5, 2026
What Alarm.com (ALRM) Said on Its Q3 Earnings Callmarketbeat.com
Alarm.com (NASDAQ:ALRM) raised its 2026 revenue and earnings outlook after reporting third-quarter results that exceeded its expectations, helped by recurring revenue growth and a temporary boost from hardware cost recoveries.
The security technology company also announced its acquisition of gate a
Via MarketBeat · November 5, 2026
What Phibro Animal Health (PAHC) Said on Its Q1 Earnings Callmarketbeat.com
Phibro Animal Health (NASDAQ:PAHC) reported a 6% increase in fiscal first-quarter sales, helped by growth in its Mineral Nutrition and Performance Products businesses, and maintained its full-year outlook despite pressure on poultry producers.
For the quarter ended September 30, 2026, net sales ros
Via MarketBeat · November 5, 2026
Citizens Financial Group Targets 18% ROTCE as Private Bank and Deal Pipeline Growmarketbeat.com
Citizens Financial Group (NYSE:CFG) expects growth in its private bank, capital markets business and consumer franchise to help it reach a key profitability target by the end of 2027, Chief Financial Officer Aunoy Banerjee said at a company news event.
Banerjee said the bank remains confident it ca
Via MarketBeat · November 5, 2026
Papa John's International Q3 Earnings Call Highlightsmarketbeat.com
Papa John's International (NASDAQ:PZZA) reported lower third-quarter sales and adjusted earnings as promotional competition and weaker customer acquisition weighed on its North American business. The pizza chain also introduced a turnaround plan centered on food quality, marketing and support for fr
Via MarketBeat · November 5, 2026
ScanSource Q1 Earnings Call Highlightsmarketbeat.com
ScanSource (NASDAQ:SCSC) raised its fiscal 2027 sales and adjusted EBITDA outlook after first-quarter revenue grew 30% year over year, though a concentration of lower-margin hardware deals and bad debt reserves in Brazil weighed on profitability.
The updated forecast includes contributions from Mic
Via MarketBeat · November 5, 2026
What Insight Enterprises (NSIT) Said on Its Q3 Earnings Callmarketbeat.com
Insight Enterprises (NASDAQ:NSIT) reported 22% revenue growth in the third quarter of 2026 and raised its full-year outlook, as demand for infrastructure hardware, cloud services and devices helped the technology solutions provider exceed its expectations.
Revenue for the quarter ended September 30
Via MarketBeat · November 5, 2026
Peloton Interactive Q1 Earnings Call Highlightsmarketbeat.com
Peloton Interactive (NASDAQ:PTON) reported higher revenue and stronger-than-expected profitability for its fiscal first quarter of 2027, helped by subscription price increases, lower recall costs and favorable tariff effects. The connected fitness company maintained its full-year outlook, which call
Via MarketBeat · November 5, 2026
Open Text Q1 Earnings Call Highlightsmarketbeat.com
Open Text (NASDAQ:OTEX) reported fiscal first-quarter revenue of $1.237 billion and maintained its full-year outlook, as growth in cloud products helped offset declines in client support, licensing and professional services revenue.
Core revenue rose 2.4% year over year to $864 million, or 2.7% in
Via MarketBeat · November 5, 2026
What Palvella Therapeutics (PVLA) Said on Its Q3 Earnings Callmarketbeat.com
Palvella Therapeutics (NASDAQ:PVLA) is preparing for a potential U.S. launch of QTORIN rapamycin after the Food and Drug Administration accepted its application for the treatment of microcystic lymphatic malformations and granted it Priority Review.
The FDA set a target action date of February 28,
Via MarketBeat · November 5, 2026
Lamar Advertising Q3 Earnings Call Highlightsmarketbeat.com
Lamar Advertising (NASDAQ:LAMR) raised its full-year funds from operations outlook after third-quarter growth in national advertising, political spending and digital billboards carried into a record October.
The outdoor advertising company expects full-year diluted adjusted funds from operations (A
Via MarketBeat · November 5, 2026
Oxford Lane Capital Q2 Earnings Call Highlightsmarketbeat.com
Oxford Lane Capital (NASDAQ:OXLC) reported a decline in net asset value and investment income for its second fiscal quarter, as management pointed to pressure on collateralized loan obligation equity from tight loan spreads and weak market sentiment.
Net asset value stood at $9.95 per share on Sept
Via MarketBeat · November 5, 2026
Evergy Q3 Earnings Call Highlightsmarketbeat.com
Evergy (NASDAQ:EVRG) raised its 2026 earnings guidance after warmer-than-normal weather and growing electricity demand helped lift third-quarter adjusted earnings, while the utility outlined further opportunities to serve large customers in Kansas and Missouri.
The company reported adjusted earning
Via MarketBeat · November 5, 2026
What Ironwood Pharmaceuticals (IRWD) Said on Its Q3 Earnings Callmarketbeat.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) raised its 2026 financial outlook after third-quarter sales of LINZESS reached $325 million, as improved net pricing and prescription demand supported the gastrointestinal drug’s performance.
The company now expects full-year U.S. LINZESS net sales of $1.2 bil
Via MarketBeat · November 5, 2026
Agenus Targets Phase 3 Colon Cancer Trial as Financing Hinges on Enrollment Milestonesmarketbeat.com
Agenus (NASDAQ:AGEN) expects to begin enrolling patients in the next few months for a Phase 3 trial of its investigational immunotherapy combination BOT/BAL in early-stage colon cancer, executives said during an investor event.
The study, called ROBIN, will enroll approximately 850 patients with hi
Via MarketBeat · November 5, 2026
IQM Quantum Computers Q3 Earnings Call Highlightsmarketbeat.com
IQM Quantum Computers (NASDAQ:IQMX) reported €8.9 million in third-quarter revenue and €42.2 million in new orders, led by a €33 million contract for an error-correction system at Finland’s CSC Supercomputing Center.
The company reiterated its full-year revenue forecast of €42 million to €47 millio
Via MarketBeat · November 5, 2026
Iovance Biotherapeutics Q3 Earnings Call Highlightsmarketbeat.com
Iovance Biotherapeutics (NASDAQ:IOVA) reported record third-quarter revenue of approximately $122 million, up 80% from a year earlier, as sales of its melanoma treatment AMTAGVI surpassed $100 million in a quarter for the first time.
The company reaffirmed its 2026 revenue guidance of $410 million
Via MarketBeat · November 5, 2026
What Interparfums (IPAR) Said on Its Q3 Earnings Callmarketbeat.com
Interparfums (NASDAQ:IPAR) reported flat third-quarter sales of $430 million as growth in its European-based operations offset a decline in its U.S. business, where delayed gift set shipments shifted approximately $10 million in sales into the fourth quarter.
The fragrance company moderately raised
Via MarketBeat · November 5, 2026
HMH Q3 Earnings Call Highlightsmarketbeat.com
HMH (NASDAQ:HMH) revised its 2026 earnings outlook as delayed equipment orders, slower rig reactivations and disruptions in the Middle East weighed on third-quarter results and cash flow. Executives said they expect activity to improve in 2027, particularly among the offshore floating rigs that use
Via MarketBeat · November 5, 2026
Aemetis Q3 Earnings Call Highlightsmarketbeat.com
Aemetis (NASDAQ:AMTX) reported third-quarter 2026 net income of $5.2 million as revenue rose 49% from a year earlier, helped by growth in its California ethanol and dairy renewable natural gas businesses and federal clean fuel production tax credits.
Revenue increased to $88.2 million from $59.2 mi
Via MarketBeat · November 5, 2026
What Goodyear Tire & Rubber (GT) Said on Its Q3 Earnings Callmarketbeat.com
Goodyear Tire & Rubber (NASDAQ:GT) reported improved third-quarter operating results but said earnings remained below expectations as weak replacement tire demand and underused factories weighed on profitability.
The company is evaluating broader changes to its manufacturing footprint, product
Via MarketBeat · November 5, 2026
What Global Water Resources (GWRS) Said on Its Q3 Earnings Callmarketbeat.com
Global Water Resources (NASDAQ:GWRS) reported lower third-quarter earnings despite higher revenue, as depreciation and operating costs tied to infrastructure investments outpaced growth in customer connections and rates.
The Arizona water utility reported net income of $1 million, or $0.03 per dilu
Via MarketBeat · November 5, 2026
What Himax Technologies (HIMX) Said on Its Q3 Earnings Callmarketbeat.com
Himax Technologies (NASDAQ:HIMX) expects fourth-quarter revenue to fall sharply from the third quarter as some automotive display customers reduce orders after building inventory earlier in the year. The forecast comes despite third-quarter profit that exceeded the company’s guidance.
The display c
Via MarketBeat · November 5, 2026
What Evotec (EVO) Said on Its Q3 Earnings Callmarketbeat.com
Evotec (NASDAQ:EVO) reported a narrower adjusted EBITDA loss for the third quarter of 2026 and reaffirmed its full-year guidance, saying it expects revenue and earnings to finish toward the upper ends of their respective ranges.
The company said stronger commercial execution in its drug discovery a
Via MarketBeat · November 5, 2026
Ally Financial Sees Auto Loan Losses on Target, Margin Growth Ahead Despite Lease Pressuremarketbeat.com
Ally Financial (NYSE:ALLY) expects retail auto loan losses to finish near the midpoint of its annual forecast and sees a path to further margin expansion, even as lease losses and higher delinquencies pressure parts of its business, Chief Financial Officer Russ Hutchinson said.
Speaking with Fideli
Via MarketBeat · November 5, 2026
Portillo's Q3 Earnings Call Highlightsmarketbeat.com
Portillo's (NASDAQ:PTLO) reported higher third-quarter sales and earnings, raised its full-year adjusted EBITDA outlook and outlined plans to close a mid- to high single-digit number of underperforming restaurants outside Chicagoland.
The restaurant chain’s revenue rose 7% from a year earlier to $1
Via MarketBeat · November 5, 2026
What KVH Industries (KVHI) Said on Its Q3 Earnings Callmarketbeat.com
KVH Industries (NASDAQ:KVHI) reported 35% year-over-year revenue growth in the third quarter of 2026, as demand for low Earth orbit satellite connectivity and managed services helped lift recurring service revenue.
The company generated total revenue of $38.4 million, up 14% from the second quarter
Via MarketBeat · November 5, 2026
What Malibu Boats (MBUU) Said on Its Q1 Earnings Callmarketbeat.com
Malibu Boats (NASDAQ:MBUU) reported a 29.9% increase in net sales for the quarter ended Sept. 30, 2026, as its Saxdor acquisition and higher shipments of Cobalt and saltwater fishing boats helped offset weaker demand in the ski and wake boat category.
Net sales rose to $252.9 million, modestly belo
Via MarketBeat · November 5, 2026
What Frontdoor (FTDR) Said on Its Q3 Earnings Callmarketbeat.com
Frontdoor (NASDAQ:FTDR) raised its full-year revenue and adjusted earnings outlook after third-quarter growth in home warranty memberships and HVAC system upgrades helped offset higher claims costs during an unusually hot summer.
The company reported third-quarter revenue of $655 million, up 6% fro
Via MarketBeat · November 5, 2026